Diaspore

All documents · source file docs/methodology/deal-v0.1-prechecks.md · changed 2026-11-03 · sha256 f49008b6cb3a

deal-v0.1 pre-checks (IDEA-014 M1)

Counts and minimum detectable AUC only. No score exists yet and no evidence-to-label relationship was computed. Produced by PYTHONPATH=src ~/.venvs/diaspore-sk122/bin/python -m diaspore.acquire.prechecks on 2026-11-03, fixed data end 2026-03-31.

Minimum detectable AUC: smallest true AUC separable from 0.5, alpha 0.05 two-sided, power 0.80, null Hanley-McNeil variance, one row per company.

(a) Comparable cells: priced deals dated on or before each as-of, stage read the day before each deal

266 live acquired_public rows; 179 have a low edge. All value edges have basis consideration_x_shares.

as-ofno trialsph0-1ph2ph3-4stage cells at n >= 10
2018-12-313872101 of 3
2020-12-315084181 of 3
2022-12-3165108262 of 3
2024-12-31841515383 of 3

These differ from the Obstacle map's cells because the map read stage on the deal date and did not apply the pre-declared merges. These counts govern (director, decisions.md "IDEA-014 D5 refinement").

(b) R2 hindcast label: later trial at a phase above the pre-deal maximum

Targets with pre-deal trials only. Deals whose horizon passes the data end are censored.

horizonuncensoredpositivescensoredminimum detectable AUC
36 months694550.920
60 months482761.000

Both exceed the registered 0.85, so M5 is descriptive and reads "cannot test" (plan rule M1(b)).

(c) R3 pools at T, positive = acquired_public row dated in (T, T+36 months]

poolT=2020 pos/negmin AUCT=2022 pos/negmin AUCuse
trial-bearing, listed at T, not terminal at T33 / 3730.64752 / 4380.619primary (ruling)
trial-bearing, any36 / 1,6830.63654 / 1,9470.612descriptive secondary
all companies, any75 / 15,2910.59498 / 15,2280.582descriptive secondary
trial-bearing, no prior ledger row of any kind3 / 1,2690.9682 / 1,4591.000dropped: degenerate

The ledger label can only fire for a listed company, so a pool with private companies largely measures "was public". All 266 targets have another ledger row, which is why the literal "no other exit" pool collapses.

(d) Targets with no trials

142 of the 266 targets have no trial row on or before the data end. They carry no stage evidence and leave the primary R3 pool.